In people with Parkinson's disease, neuropsychiatric signs and symptoms are common
throughout the disease course. These symptoms can be disabling and as clinically relevant …

Dopamine agonists (DAs) have demonstrated efficacy for the treatment of Parkinson's
disease (PD) but are limited by adverse effects (AEs). DAs can vary considerably in their …

Objective To empirically test whether apathy and impulse control disorders (ICDs) represent
independent, opposite ends of a motivational spectrum. Methods In this single-center, cross …

Deep brain stimulation (DBS) for Parkinson's disease successfully alleviates motor
symptoms, but unanticipated changes in personality, self, and relationships can occur. Little …

Addictions involve a spectrum of behaviors that encompass features of impulsivity and
compulsivity, herein referred to as impulsive-compulsive spectrum disorders (ICSDs). The …

Background The effects of subthalamic stimulation (subthalamic nucleus-deep brain
stimulation, STN-DBS) on impulsive and compulsive behaviours (ICB) in Parkinson's …

Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of
dopaminergic neurons in the substantia nigra pars compacta (SNpc) in the midbrain …

Objective This study was undertaken to evaluate whether the feedback‐related negativity
(FRN)—a neurophysiological marker of incentive processing—can be used to predict the …

Parkinson disease (PD) is a complex heterogeneous neurodegenerative disorder.
Association studies have revealed numerous genetic risk loci and variants, and about 5 …

Background and Objectives: Parkinson's disease (PD) is one of the most common
neurodegenerative diseases in the world. It is characterized by the presence of not only …